<DOC>
	<DOCNO>NCT00598234</DOCNO>
	<brief_summary>We propose administration perioperative celecoxib effective control postoperative VAS pain score , improve rehabilitation result , decrease narcotic usage total knee replacement patient .</brief_summary>
	<brief_title>Perioperative Pain Control With Celecoxib ( Celebrex ) Total Knee Arthroplasty</brief_title>
	<detailed_description>Total knee replacement effective method treat end-stage osteoarthritis . However , post-operative pain still bother problem . Pre-emptive analgesia define antinociceptive treatment prevents pain onset . Preoperative analgesia think effective equal post-operative dose . Surgical trauma induces synthesis prostaglandin , sensitize peripheral nociceptors.Non-steroidal anti-inflammatory drug ( NSAIDs ) inhibit prostaglandin synthesis periphery spinal cord , therefore decrease post-operative hyperalgesic state . Celebrex ( Celecoxib ) nonsteroidal anti-inflammatory drug ( NSAID ) use treat arthritis , pain , menstrual cramp , colonic polyp . Prostaglandins chemical important contributor inflammation arthritis cause pain , fever , swell tenderness . Celecoxib block enzyme make prostaglandin ( cyclooxygenase 2 ) , result low concentration prostaglandin . As consequence , inflammation accompany pain , fever , swell tenderness reduce . Celecoxib differs NSAIDs cause less inflammation ulceration stomach intestine ( least short-term treatment ) interfere clot blood . The study group receive 400mg oral celecoxib 1 hr prior total knee replacement surgery , 200mg every 12 hr , along PCA morphine , first five post-operative day . The control group receive placebo , along PCA morphine postoperative period . All patient spinal anesthesia hemovac drain tube insert postoperative blood loss evaluation . Specific aims goal : 1. establish good rehabilitation result low VAS pain score administration perioperative celecoxib total knee replacement patient . 2. establish morphine spar effect perioperative celecoxib administration . 3. evaluate risk prescribe perioperative celecoxib .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients receive total knee replacement recruit study . subject endstage renal disease , cerebral vascular accident , peptic ulcer , longterm usage NSAIDs .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>